In the context of cancer, PTH can be implicated in several ways. Certain cancers, particularly those that metastasize to the bone, can disrupt normal calcium regulation, leading to hypercalcemia. This condition is characterized by elevated calcium levels in the blood, often as a result of parathyroid hormone-related protein (PTHrP) production by tumors.
